Zacks Investment Research on MSN2d
PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know
Shares of Pliant Therapeutics PLRX have plunged 88.5% in the past three months following recent setbacks in the clinical ...
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across ...
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types
Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested ...
Pliant Therapeutics announces interim Phase 1 data from PLN-101095
Pliant Therapeutics (PLRX) announced data from the first three of five potential cohorts of its ongoing Phase 1 dose escalation clinical trial ...
GamesIndustry.biz3d
CD Projekt reports third best year for profit despite no major launches in 2024
CD Projekt has released its financial results for 2024, reporting its third best year in terms of net profit despite ...
Warsaw Business Journal4d
President Duda signs law to PLN 60 bln for nuclear power plant
Polish President Andrzej Duda has signed a law allocating PLN 60 billion for the country’s first nuclear power plant. The ...